Inhibition of BTK and PI3Kδ impairs the development of human JMML stem and progenitor cells

Juvenile myelomonocytic leukemia (JMML) is an aggressive myeloproliferative neoplasia that lacks effective targeted chemotherapies. Clinically, JMML manifests as monocytic leukocytosis, splenomegaly with consequential thrombocytopenia. Most commonly, patients have gain-of-function (GOF) oncogenic mu...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramdas, Baskar, Yuen, Lisa Deng, Palam, Lakshmi Reddy, Patel, Roshini, Pasupuleti, Santhosh Kumar, Jideonwo, Victoria, Zhang, Ji, Maguire, Callista, Wong, Eric, Kanumuri, Rahul, Zhang, Chujing, Sandusky, George, Chan, Rebecca J., Zhang, Chi, Stieglitz, Elliot, Haneline, Laura, Kapur, Reuben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263321/
https://www.ncbi.nlm.nih.gov/pubmed/35443935
http://dx.doi.org/10.1016/j.ymthe.2022.04.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263321/
https://www.ncbi.nlm.nih.gov/pubmed/35443935
http://dx.doi.org/10.1016/j.ymthe.2022.04.009

Ejemplares similares